$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
How much does the Lao version of tofacitinib cost?
2026-02-01 22:25:32
Check Details
How much does the Indian version of cycloserine cost? Is it more competitive?
2026-02-01 22:25:32
Check Details
Will discontinuation of linezolid lead to drug resistance? How to prevent bacteria from developing drug resistance after long-term use?
2026-02-01 22:25:32
Check Details
Are there generic versions of ribociclib? Do generic ribociclib work the same as genuine ribociclib?
2026-02-01 22:25:32
Check Details
Sotoraxib combined with panitumumab provides an effective targeted therapy option for patients with KRAS G12C+mCRC
2026-02-01 22:25:32
Check Details
Adagarasib improves prognosis in KRAS G12C mutated lung cancer
2026-02-01 22:25:32
Check Details
Which generation of targeted drug is afatinib? What is its role in lung cancer treatment?
2026-02-01 22:25:32
Check Details
What is the domestic price of 2025 Dali Raisin tablets? Analysis of the latest price information
2026-02-01 22:25:32
Check Details
Lynparib induces improvement in OS rate in platinum-sensitive germline/somatic BRCA+ recurrent ovarian cancer
2026-02-01 22:25:32
Check Details
The CRISTALLO study of venetoclax/venetoclax/Obinutuzumab achieved excellent MRD in CLL
2026-02-01 22:25:32
Check Details
Acemini Price Analysis: Latest Prices and Purchasing Channels in 2025
2026-02-01 22:25:32
Check Details
Study highlights long-term efficacy of ritexitinib in treating alopecia areata
2026-02-01 22:25:32
Check Details
1
2
...
1351
1352
1353
1354
1355
1356
1357
...
10212
10213
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Venetoclax (Venetoclax): Balancing Precision with Risk Management in Hematologic Malignancies
2
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
3
A Comprehensive Guide to Benralizumab Adverse Reactions: Prevention and Management
4
Lemborexant: A Dual Orexin Receptor Antagonist Revolutionizing Insomnia Treatment
5
Breztri Aerosphere Approved by US FDA for Maintenance Treatment of Asthma in Patients Aged 12 Years and Older
6
Datopotamab Deruxtecan as First-Line Treatment for Advanced Triple-Negative Breast Cancer: Full Interpretation of the Phase III TROPION-Breast02 Trial
7
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer
8
Vibegron 2026 Research Updates: New Evidence for Overactive Bladder Treatment
9
Elafibranor for Cholestatic Liver Diseases: Efficacy Maintenance and Drug Resistance Analysis
10
Benzgalantamine (Zunveyl) for Alzheimer's Disease: Efficacy and Optimal Treatment Stages
11
Loargys(Pegzilarginase-nbln) Complete Medication Guide: Pre-Treatment Assessment, Monitoring and Home Administration
12
Plerixafor Complete Side Effect Guide: Adverse Reaction Classification and Professional Management